Antipsychotic-Induced Type 2 Diabetes: Evidence From a Large Health Plan Database
Tóm tắt
Từ khóa
Tài liệu tham khảo
Claghorn, 1987, The risks and benefits of clozapine versus chlorpromazine., J Clin Psychopharmacol, 7, 377, 10.1097/00004714-198712000-00002
Wirshing, 1999, Risperidone in treatment-refractory schizophrenia., Am J Psychiatry, 156, 1374, 10.1176/ajp.156.9.1374
Davies, 1998, Risperidone versus haloperidol: I. Meta-analysis of efficacy and safety., Clin Ther, 20, 58, 10.1016/S0149-2918(98)80034-9
Chouinard, 1993, A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients., J Clin Psychopharmacol, 13, 25, 10.1097/00004714-199302000-00004
Breier, 1999, Comparative efficacy of olanzapine and haloperidol for patients with treatment-resistant schizophrenia., Biol Psychiatry, 45, 403, 10.1016/S0006-3223(98)00291-1
Tran, 1999, Olanzapine versus haloperidol in the treatment of schizoaffective disorder. Acute and long-term therapy., Br J Psychiatry, 174, 15, 10.1192/bjp.174.1.15
Dev, 2000, Quetiapine: a review of its safety in the management of schizophrenia., Drug Saf, 23, 295, 10.2165/00002018-200023040-00003
Emsley, 2000, A comparison of the effects of quetiapine (‘seroquel’) and haloperidol in schizophrenic patients with a history of and a demonstrated, partial response to conventional antipsychotic treatment. PRIZE Study Group., Int Clin Psychopharmacol, 15, 121, 10.1097/00004850-200015030-00001
Peuskens, 1997, A comparison of quetiapine and chlorpromazine in the treatment of schizophrenia., Acta Psychiatr Scand, 96, 265, 10.1111/j.1600-0447.1997.tb10162.x
Daniel, 2000, Ziprasidone: comprehensive overview and clinical use of a novel antipsychotic., Expert Opin Investig Drugs, 9, 819, 10.1517/13543784.9.4.819
Keck, 2001, Ziprasidone in the short-term treatment of patients with schizoaffective disorder: results from two double-blind, placebo-controlled, multicenter studies., J Clin Psychopharmacol, 21, 27, 10.1097/00004714-200102000-00007
Alvir, 1993, Clozapine-induced agranulocytosis. Incidence and risk factors in the United States., N Engl J Med, 329, 162, 10.1056/NEJM199307153290303
Henderson, 2000, Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: a five-year naturalistic study., Am J Psychiatry, 157, 975, 10.1176/appi.ajp.157.6.975
Wehring, 2000, Diabetes mellitus associated with clozapine therapy., Pharmacotherapy, 20, 844, 10.1592/phco.20.9.844.35201
Wu, 2000, Hyperglycemia, hyperlipemia, and periodic paralysis: a case report of new side effects of clozapine., Prog Neuropsychopharmacol Biol Psychiatry, 24, 1395, 10.1016/S0278-5846(00)00141-X
Smith, 1999, Clozapine-induced diabetic ketoacidosis., Aust N Z J Psychiatry, 33, 120, 10.1080/0004867900027
Colli, 1999, Diabetic ketoacidosis associated with clozapine treatment., Diabetes Care, 22, 176, 10.2337/diacare.22.1.176a
Wirshing, 1998, Novel antipsychotics and new onset diabetes., Biol Psychiatry, 44, 778, 10.1016/S0006-3223(98)00100-0
Hagg, 1998, Prevalence of diabetes and impaired glucose tolerance in patients treated with clozapine compared with patients treated with conventional depot neuroleptic medications., J Clin Psychiatry, 59, 294, 10.4088/JCP.v59n0604
Popli, 1997, Clozapine and associated diabetes mellitus., J Clin Psychiatry, 58, 108, 10.4088/JCP.v58n0304
Peterson, 1996, Diabetic ketoacidosis from clozapine and lithium cotreatment., Am J Psychiatry, 153, 737, 10.1176/ajp.153.5.737b
Kostakoglu, 1996, Ketoacidosis as a side-effect of clozapine: a case report., Acta Psychiatr Scand, 93, 217, 10.1111/j.1600-0447.1996.tb10635.x
Koval, 1994, Diabetic ketoacidosis associated with clozapine treatment., Am J Psychiatry, 151, 1520, 10.1176/ajp.151.10.1520b
Kamran, 1994, Severe hyperglycemia associated with high doses of clozapine., Am J Psychiatry, 151, 1395, 10.1176/ajp.151.9.1395a
Muench, 2001, Diabetes mellitus associated with atypical antipsychotic medications: new case report and review of the literature., J Am Board Fam Pract, 14, 278
Melkersson, 2000, Elevated levels of insulin, leptin, and blood lipids in olanzapine-treated patients with schizophrenia or related psychoses., J Clin Psychiatry, 61, 742, 10.4088/JCP.v61n1006
Bettinger, 2000, Olanzapine-induced glucose dysregulation., Ann Pharmacother, 34, 865, 10.1345/aph.19327
Rigalleau, 2000, Diabetes as a result of atypical anti-psychotic drugs—a report of three cases., Diabet Med, 17, 484, 10.1046/j.1464-5491.2000.00296.x
Goldstein, 1999, New-onset diabetes mellitus and diabetic ketoacidosis associated with olanzapine treatment., Psychosomatics, 40, 438, 10.1016/S0033-3182(99)71210-7
Gatta, 1999, Diabetic ketoacidosis with olanzapine treatment., Diabetes Care, 22, 1002, 10.2337/diacare.22.6.1002
Lindenmayer, 1999, Olanzapine-induced ketoacidosis with diabetes mellitus., Am J Psychiatry, 156, 1471, 10.1176/ajp.156.9.1471
Fertig, 1998, Hyperglycemia associated with olanzapine., J Clin Psychiatry, 59, 687, 10.4088/JCP.v59n1208c
Procyshyn, 2000, New-onset diabetes mellitus associated with quetiapine [letter]., Can J Psychiatry, 45, 668
Sobel, 1999, New-onset diabetes mellitus associated with the initiation of quetiapine treatment [letter]., J Clin Psychiatry, 60, 556, 10.4088/JCP.v60n0809f
Croarkin, 2000, Diabetic ketoacidosis associated with risperidone treatment?, Psychosomatics, 41, 369, 10.1176/appi.psy.41.4.369
Melamed, 1998, Risperidone treatment for a patient suffering from schizophrenia and IDDM [letter]., Can J Psychiatry, 43, 956
Mohan, 1999, Schizophrenia and diabetes mellitus [letter]., Br J Psychiatry, 174, 180, 10.1192/bjp.174.2.180b
Aruna, 1995, Chlorpromazine induced diabetes mellitus., J Assoc Physicians India, 43, 146
Tollefson, 1983, Nonketotic hyperglycemia associated with loxapine and amoxapine: case report., J Clin Psychiatry, 44, 347
Proakis, 1971, Phenothiazine-induced hyperglycemia: relation to CNS and adrenal effects., Proc Soc Exp Biol Med, 137, 1385, 10.3181/00379727-137-35794
Lindenmayer, 2003, Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics., Am J Psychiatry, 160, 290, 10.1176/appi.ajp.160.2.290
Newcomer, 2002, Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia., Arch Gen Psychiatry, 59, 337, 10.1001/archpsyc.59.4.337
Taylor, 2000, Atypical antipsychotics and weight gain—a systematic review., Acta Psychiatr Scand, 101, 416, 10.1034/j.1600-0447.2000.101006416.x
Allison, 1999, Antipsychotic-induced weight gain: a comprehensive research synthesis., Am J Psychiatry, 156, 1686, 10.1176/ajp.156.11.1686
Mir, 2001, Atypical antipsychotics and hyperglycaemia., Int Clin Psychopharmacol, 16, 63, 10.1097/00004850-200103000-00001
Liebzeit, 2001, New onset diabetes and atypical antipsychotics., Eur Neuropsychopharmacol, 11, 25, 10.1016/S0924-977X(00)00127-9
Hedenmalm, 2002, Glucose intolerance with atypical antipsychotics., Drug Saf, 25, 1107, 10.2165/00002018-200225150-00005
Sernyak, 2002, Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia., Am J Psychiatry, 159, 561, 10.1176/appi.ajp.159.4.561
Koro, 2002, Assessment of independent effect of olanzapine and risperidone on risk of diabetes among patients with schizophrenia: population based nested case-control study., BMJ, 325, 243, 10.1136/bmj.325.7358.243
Caro, 2002, The risk of diabetes during olanzapine use: a retrospective database analysis., J Clin Psychiatry, 63, 1135, 10.4088/JCP.v63n1208
Gianfrancesco, 2002, Differential effects of risperidone, olanzapine, clozapine, and conventional antipsychotics on type 2 diabetes: findings from a large health plan database., J Clin Psychiatry, 63, 920, 10.4088/JCP.v63n1010
Dixon, 2000, Prevalence and correlates of diabetes in national schizophrenia samples., Schizophr Bull, 26, 903, 10.1093/oxfordjournals.schbul.a033504
Mukherjee, 1996, Diabetes mellitus in schizophrenic patients., Compr Psychiatry, 37, 68, 10.1016/S0010-440X(96)90054-1
Lilliker, 1980, Prevalence of diabetes in a manic-depressive population., Compr Psychiatry, 21, 270, 10.1016/0010-440X(80)90030-9
Cassidy, 1999, Elevated frequency of diabetes mellitus in hospitalized manic-depressive patients., Am J Psychiatry, 156, 1417, 10.1176/ajp.156.9.1417
Borison, 1996, Changing antipsychotic medication: guidelines on the transition to treatment with risperidone. The Consensus Study Group on Risperidone Dosing., Clin Ther, 18, 592, 10.1016/S0149-2918(96)80211-6
Martinez-Maldonado, 1973, Lithium carbonate-induced nephrogenic diabetes insipidus and glucose intolerance., Arch Intern Med, 132, 881, 10.1001/archinte.1973.03650120081015
Breum, 1995, Long-term effects of fluoxetine on glycemic control in obese patients with non-insulin-dependent diabetes mellitus or glucose intolerance: influence on muscle glucogen synthase and insulin receptor kinase activity., Metabolism, 44, 1570, 10.1016/0026-0495(95)90077-2